Trileptal vs. Lamictal xr

Summary

We compare the side effects and drug effectiveness of Trileptal and Lamictal xr. The study is created by eHealthMe based on reports of 124,813 people who take Trileptal and Lamictal xr, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on oxcarbazepine and lamotrigine (the active ingredients of Trileptal and Lamictal xr, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. (latest outcomes from Trileptal 18,637 users)

What is Lamictal xr?

Lamictal xr has active ingredients of lamotrigine. It is often used in epilepsy. (latest outcomes from Lamictal xr 1,303 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 10, 2019

124,813 people who take Trileptal and Lamictal xr are studied.


Number of reports submitted per year:

Trileptal vs Lamictal xr drug comparison reports.

Drugs in this study:

  • Trileptal (oxcarbazepine)
  • Lamictal Xr (lamotrigine)

Most common side effects:

Trileptal:
  1. Rash
  2. Drug Ineffective
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Pyrexia (fever)
  5. Nausea (feeling of having an urge to vomit)
  6. Headache (pain in head)
  7. Dizziness
  8. Fatigue (feeling of tiredness)
  9. Depression
  10. Vomiting
Lamictal Xr:
  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Drug Ineffective
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Dizziness
  5. Headache (pain in head)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Nausea (feeling of having an urge to vomit)
  8. Fatigue (feeling of tiredness)
  9. Vomiting
  10. Fall

Most common side effects experienced by people in long term use:

Trileptal:
  1. Rash
  2. Depression
  3. Drug Ineffective
  4. Anxiety
  5. Dizziness
  6. Fatigue (feeling of tiredness)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Nausea (feeling of having an urge to vomit)
  9. Headache (pain in head)
  10. Insomnia (sleeplessness)
Lamictal Xr:
  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Dizziness
  4. Headache (pain in head)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Drug Ineffective
  7. Fall
  8. Weight Increased
  9. Vomiting
  10. Depression

Drug effectiveness:

Trileptal:
  • not at all: 3.47 %
  • somewhat: 18.19 %
  • moderate: 30.75 %
  • high: 31.13 %
  • very high: 16.46 %
Lamictal Xr:
  • not at all: 4.85 %
  • somewhat: 18.58 %
  • moderate: 28.05 %
  • high: 31.83 %
  • very high: 16.69 %

Do you take Trileptal or Lamictal xr?

You are not alone:




Related publications that referenced our studies

Related studies:



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.